Price-Reporting Basics under Medicaid, Medicare and the PHS 340B Program: Planning for Both Compliance and Commercial Success

This monograph summarizes the price calculation and reporting obligations under the Medicaid Drug Rebate Program, the Public Health Service (PHS) Drug Pricing Program, and the Medicare Average Sales Price reporting requirement.

The monograph is available for purchase by clicking here –  as either a stand-alone purchase or as the first of six that will make up the first volume in the monograph series. Note that Hogan & Hartson partner Joy Sturm and associate Allison Pugsley are authors of another monograph in this first volume, set for publication in March 2010, titled, "Selling Pharmaceuticals to the Federal Government: Federal Supply Schedule Contracting and Federal Ceiling Price Requirements", and a purchase of the first volume will entitle the purchaser to that monograph as well.

This first monograph alone is $195 for FDLI members and $295 for non-members. The first volume of the monograph series (made up of six monographs) is priced at $495 for members, or $695 for non-members.

SPECIAL DISCOUNT: Through FDLI, we are authorized to offer a $100 discount on the purchase price, equally applicable to the purchase of the monograph alone or the first six that make up the first volume. To access the discount, enter the following coupon code where indicated - CURRANMONO -  no spaces, all caps.  This discount offer is available through September 30, 2009.

Download PDF Share Back To Listing
Loading data